Eli Lilly and Company
AMINO PYRIMIDINE SSAO INHIBITORS
Last updated:
Abstract:
The present invention provides compounds of the Formula (I), or a pharmaceutically acceptable salt thereof, where n and R1 are defined herein, methods of treating patients for liver disease, and processes for preparing the compounds,
Status:
Application
Type:
Utility
Filling date:
26 Sep 2019
Issue date:
20 Aug 2020